EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cost‐Effectiveness Analysis of Transoral Robotic Surgery Versus Radiotherapy Alone for Early‐Stage HPV ‐Associated Oropharynx Squamous Cell Carcinoma in Australia

Lan Gao iD, June Corry, Danny Rischin, Tao Xing

Journal of Medical Imaging and Radiation Oncology · 15.05.2026

DOI: 10.1111/1754-9485.70114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, online erschienen am 15.05.2026. Verfasst von Lan Gao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Deakin Health Economics, Institute for Health Transformation, Faculty of Health, Deakin University, Burwood, Victoria, Australia. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Queensland Health, Tropical Australian Academic Health Centre, Townsville Hospital and Health Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Transoral robotic surgery (TORS) and radiotherapy are both recognised as effective treatment options for early‐stage HPV‐associated oropharyngeal squamous cell carcinoma (HPV‐OPSCC). TORS offers the benefit of a shorter total treatment duration; however, a proportion of patients require adjuvant radiotherapy with or without concurrent chemotherapy. Given the equivalence in oncological outcomes and difference in potential costs associated with these two treatments, we sought to perform an economic analysis to assess the incremental cost‐effectiveness of TORS compared to radiotherapy.

Methods

We developed a Markov model to assess the cost‐effectiveness of TORS versus radiotherapy for clinical stage T1‐2 N0‐1 (AJCC 7th edition) HPV‐OPSCC. Utility values for health states were informed by EQ‐5D‐5L from a TROG 12.01. We adopted the Australian healthcare perspective to measure healthcare costs and outcomes, and costs were valued in 2023 Australian dollars (AUD). The incremental cost‐effectiveness ratio (ICER) was calculated as the ratio of incremental cost against the incremental quality‐adjusted life years (QALY) between two treatment groups. Parameter uncertainties were assessed through sensitivity analysis.

Results

The total costs/QALY for TORS and radiotherapy were $85,317/8.995 QALY and $57,833/8.519 QALY, respectively. This resulted in an ICER of $57,749/QALY gained with TORS. In sensitivity analysis, ICER was highly sensitive to the cost of TORS, distant recurrent disease, probability of salvage surgery after radiotherapy, discount rate, and the locoregional recurrent disease.

Conclusion

From an Australian healthcare system perspective, TORS is not cost‐effective compared to radiotherapy alone for early‐stage HPV‐OPSCC based on healthcare associated cost.

Schlagwörter

Stichwörter der Autor:innen

HPV‐associated oropharyngeal squamous cell carcinomahealth economicsincremental cost‐effectiveness ratiooropharyngeal squamous cell carcinomaradiotherapytransoral robotic surgery

Autor:innen und Institutionen

  • Deakin Health Economics, Institute for Health Transformation, Faculty of Health, Deakin University, Burwood, Victoria, Australia.
  • GenesisCare Radiotherapy, St. Vincent's Hospital, Melbourne, Victoria, Australia.
  • Department of Medicine, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Radiation Oncology, Townsville University Hospital, Townsville, Queensland, Australia.

ORCID-Profile: Lan Gao

Förderung

  • Queensland Health
  • Tropical Australian Academic Health Centre
  • Townsville Hospital and Health Service
  • Royal Australian and New Zealand College of Radiologists

Zitieren

APA

Gao, L., Corry, J., Rischin, D., & Xing, T. (2026). Cost‐Effectiveness Analysis of Transoral Robotic Surgery Versus Radiotherapy Alone for Early‐Stage HPV ‐Associated Oropharynx Squamous Cell Carcinoma in Australia. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/1754-9485.70114

Vancouver

Gao L, Corry J, Rischin D, Xing T. Cost‐Effectiveness Analysis of Transoral Robotic Surgery Versus Radiotherapy Alone for Early‐Stage HPV ‐Associated Oropharynx Squamous Cell Carcinoma in Australia. Journal of Medical Imaging and Radiation Oncology. 2026. doi:10.1111/1754-9485.70114

BibTeX
@article{Gao2026,
  author = {Gao, Lan and Corry, June and Rischin, Danny and Xing, Tao},
  title = {Cost‐Effectiveness Analysis of Transoral Robotic Surgery Versus Radiotherapy Alone for Early‐Stage HPV ‐Associated Oropharynx Squamous Cell Carcinoma in Australia},
  journal = {Journal of Medical Imaging and Radiation Oncology},
  year = {2026},
  doi = {10.1111/1754-9485.70114}
}
Kostenlos starten →